Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human IFNB1 Antibodies:
anti-Mouse (Murine) IFNB1 Antibodies:
anti-Rat (Rattus) IFNB1 Antibodies:
Go to our pre-filtered search.
Human Polyclonal IFNB1 Primary Antibody for ELISA, ICC - ABIN4321105
Colonna: TLR pathways and IFN-regulatory factors: to each its own. in European journal of immunology 2007
Show all 4 Pubmed References
Human Polyclonal IFNB1 Primary Antibody for IHC, ELISA - ABIN1002472
Gresser: Wherefore interferon? in Journal of leukocyte biology 1997
Show all 2 Pubmed References
Chicken Polyclonal IFNB1 Primary Antibody for Func, IP - ABIN2474124
Sick, Schultz, Staeheli: A family of genes coding for two serologically distinct chicken interferons. in The Journal of biological chemistry 1996
Show all 3 Pubmed References
Rat (Rattus) Polyclonal IFNB1 Primary Antibody for ELISA, WB - ABIN285821
Matsumoto, Takahashi, Shiva, Kawanishi, Kremenik, Kato, Yano: The reduction of voluntary physical activity after poly I:C injection is independent of the effect of poly I:C-induced interferon-beta in mice. in Physiology & behavior 2008
Human Polyclonal IFNB1 Primary Antibody for IF (p), IHC (p) - ABIN728158
Quek, Luff, Cheung, Kozlov, Gatei, Lee, Bellingham, Noakes, Lim, Barnett, Dingwall, Wolvetang, Mashimo, Roberts, Lavin: Rats with a missense mutation in Atm display neuroinflammation and neurodegeneration subsequent to accumulation of cytosolic DNA following unrepaired DNA damage. in Journal of leukocyte biology 2016
Human Monoclonal IFNB1 Primary Antibody for ELISA - ABIN2474122
Horie, Miyazaki, Nonogi, Takizawa, Nagao, Nishida, Kubota, Kawai: Kinetic analyses of creatine kinase release patterns in patients with acute myocardial infarction undergoing emergency coronary arteriography. in Japanese circulation journal 1990
Show all 2 Pubmed References
The review focuses on the value of the type I and III interferon (show IFNA Antibodies) subtypes (alphas, beta and lambdas) as therapeutics for prevention and treatment of viral infections (influenza, herpes, human immunodeficiency virus and hepatitis viruses).
This review briefly discusses the dysregulation of main T cell subpopulations in CNS autoimmunity and summarized the T cell targeted effects of endogenous and exogenous IFN-beta in health and EAE/MS, with emphasis on the direct actions of IFN-beta on each T cell subset involved in the disease.
c-Cbl (show CBL Antibodies) negatively regulates IFN-beta signaling and cellular antiviral response by promoting IRF3 (show IRF3 Antibodies) ubiquitination and degradation.
YPEL5 silencing enhanced the induction of IFNB1 by pattern recognition receptors and phosphorylation of TBK1 (show TBK1 Antibodies)/IKBKE (show IKBKE Antibodies) kinases, whereas co-immunoprecipitation experiments revealed that YPEL5 interacted physically with IKBKE (show IKBKE Antibodies).
The effect of topical TREX1 (show TREX1 Antibodies) knockdown and local interferon (show IFNA Antibodies) production on HIV transmission in human cervicovaginal explants and humanized mice, is reported.
this study shows that the IFN-beta/STAT1 (show STAT1 Antibodies) pathway is dysregulated in inflammatory bowel disease
results demonstrate that Sphingosine 1-phosphate lyase (SPL (show SGPL1 Antibodies)) is a host factor that augments type I IFN responses during influenza A virus infection; study delineates the relationship between IKKepsilon (show IKBKE Antibodies) and SPL (show SGPL1 Antibodies), which provides a mechanistic understanding of the pro-IFN activity of SPL (show SGPL1 Antibodies)
results suggest that, in addition to its well-known signaling activity, IFN-beta may be directly antimicrobial and be part of a growing family of cytokines and chemokines, called kinocidins, that also have antimicrobial properties.
This study demonstrates a novel pathway for elevated IFNbeta signaling in SLE that is not dependent on stimulation by immune complexes but rather is cell intrinsic and critically mediated by IFNbeta and MAVS (show MAVS Antibodies).
G45R mutation of NS1 (show PTPN11 Antibodies) slightly decreased NS1 (show PTPN11 Antibodies) binding to dsRNA but did not interfere with its suppression of RIG-I (show DDX58 Antibodies)-mediated type I IFN production.
Rb selectively inhibits innate IFN-beta production by enhancing deacetylation of Ifnb1 promoter, exhibiting a previous unknown non-classical role in innate immunity, which also suggests a role of Rb in the regulation of type I IFN production in inflammatory or autoimmune diseases.
The TBK1 (show TBK1 Antibodies) Y179A mutant failed to rescue type I IFN production by virally infected RAW264.7 macrophages deficient in TBK1 (show TBK1 Antibodies).
this study shows that poly I:C treated PAR-1 (show MARK2 Antibodies)-/- mice given the thrombin (show F2 Antibodies) inhibitor dabigatran etexilate exhibited less IFNbeta and CXCL10 (show CXCL10 Antibodies) expression in the spleen and plasma
The data demonstrate that an atypical TLR7 (show TLR7 Antibodies) signaling pathway contributes to type interferon-beta expression during Y. pestis infection and suggest that the TLR7 (show TLR7 Antibodies)-driven type I IFN response plays an important role in determining the outcome of plague.
Long-term exposure to atmospheric particulates, PM2.5 up-regulated H3K4 and H3K9 methylation in IL-6 (show IL6 Antibodies) and IFN-beta promoter regions through down-regulating Kdm6a (show KDM6A Antibodies) expression. The results suggest that short-term exposure to PM2.5 significantly enhances the survival rate of influenza A-contaminated mice, while long-term PM2.5 inhalation lowers the capacity of pulmonary macrophages to secrete IL-6 (show IL6 Antibodies) and IFN-beta.
Extracellular ATP reduces the replication of VSV, Newcastle disease virus, murine leukemia virus and HSV in vivo and in vitro through the P2X7 receptor (show P2RX7 Antibodies); ATP increases IFN-beta expression. Mechanistically, ATP facilitates IFN-beta secretion through P38 (show CRK Antibodies)/JNK (show MAPK8 Antibodies)/ATF-2 (show ATF2 Antibodies) signaling pathways, which are crucial in promoting antiviral immunity.
study reports that mitochondrial antiviral signaling protein (MAVS (show MAVS Antibodies)), -mediated IFN-alpha (show IFNA Antibodies)/beta production and IFNAR (show IFNAR1 Antibodies) signaling are required for alloimmune responses to the human K1 Ag in a murine model of inflammation-induced alloimmunization
BVDV2-E significantly increased IFN-beta activity compared to BVDV2-wt.
The data confirm the involvement of EHMT2 (show EHMT2 Antibodies) in the epigenetic regulation of IFN-b and demonstrate the activation of a general antiviral state after EHMT2 (show EHMT2 Antibodies) inhibition.
The authors provide evidence that ICP27 protein encoded by bovine herpesvirus type 1, a viral early protein that shuttles between the nucleus and cytoplasm inhibits transcriptional activity of two bovine IFN-beta gene promoters (IFN-beta1 and IFN-beta3).
The authors demonstrate that bovine herpesvirus 1 bICP0 effectively inhibits bovine IFN-beta promoter activity and induces IRF3 (show IRF3 Antibodies) degradation.
These studies provide evidence that virus infection differentially stimulates expression of the three bovine IFN-beta genes.
recombinant bovine respiratory syncytial virus lacking the NS proteins, and those lacking NS2 in particular, are strong inducers of IFN-alpha (show IFNA Antibodies)/beta in bovine nasal fibroblasts and bronchoalveolar macrophages.
Nuclear export of NSP1alpha of porcine reproductive and respiratory syndrome virus was necessary for its ability for IFN beta inhibition.
Porcine deltacoronavirus nsp5 (show SPECC1 Antibodies), the 3C-like protease, inhibits interferon-beta production through the cleavage of NEMO (show IKBKG Antibodies).
Highly pathogenic Porcine reproductive and respiratory syndrome virus modulates Interferon-beta expression mainly through attenuating IRF-3 (show IRF3 Antibodies) phosphorylation.
Porcine epidemic diarrhea virus nsp1 inhibited the IFN-beta and IRF3 (show IRF3 Antibodies) promoter activities.
poIFIT3 plays a significant role in the clearance of swine influenza virus in pigs and potentiates IFN-beta production.
DDX41 (show DDX41 Antibodies) is involved in the dsDNA- and dsDNA-virus-mediated type IFN-beta signaling pathway in porcine kidney cells.
VIral NS4 (show SOS1 Antibodies) protein antagonizes beta interferon (show IFNA Antibodies) expression by targeting the NF-kappaB (show NFKB1 Antibodies) essential modulator.
Swine IFN-beta promotes genetic mutation of porcine reproductive and respiratory syndrome virus.
Expression of LSm14A (show LSM14A Antibodies) in HEK293 or Marc (show CCL7 Antibodies)-145 cells enhanced activities of IFN-beta and NF-kappaB (show NFKB1 Antibodies) promoters, induced IFN-beta transcription, and potentiated IFN-beta promoter activation, indicating that LSm14A (show LSM14A Antibodies) is a potential signal molecule (show WNT4 Antibodies) in the IFN-beta pathway.
Overall, data provide evidence for the possible role of PI3K in the activation of the transcription of IFN-alpha (show IFNA Antibodies)/beta by PRRSV; study concludes that PRRSV inhibits the induction of IFN-alpha (show IFNA Antibodies) in monocyte-derived dendritic cells by as yet undefined post-transcriptional mechanisms.
either JC1 or DS1 C/EBP site is sufficient to mediate IFN beta-induced down-regulation of SIV long terminal repeat activity and virus replication in macrophages
Hepatitis A virus protein 2B suppresses beta interferon (show IFNA Antibodies) (IFN) gene transcription by interfering with IFN regulatory factor 3 activation.
suppresses the growth of rat glioma cells
, fibroblast interferon
, interferon beta
, interferon, beta 1
, interferon beta-1
, interferon beta 1
, interferon type B
, interferon, beta 1, fibroblast
, IFN-alpha/beta receptor 2
, interferon alpha/beta receptor 2
, interferon, beta; receptor
, interferon-alpha/beta receptor 2
, interferon-alpha/beta receptor beta chain
, type I interferon receptor 2